All lobbying clients
Invivyd
Invivyd has lobbied on its own behalf and been represented by 2 lobbying firms in 13 filings since 2025, with $460,000 in reported spending; the newest was posted October 20, 2026.
Biopharmaceutical company
$460,000
Reported spend
13
Filings counted
2
Outside firms hired
0
Bills named
Who filed for this client
3
- Forbes-Tate $300,000
- Invivyd, Inc. $160,000
- King & Spalding LLP $0
Reported by year
2 years
- 2026 $440,000
- 2025 $20,000
Issues lobbied
2
Agencies and chambers lobbied
6
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Food & Drug Administration (FDA)
- Health & Human Services, Dept of (HHS)
- White House Office
Recent filings
13 total
Q3 report
View →
Q3 report
View →
Q2 report
View →
Q2 report
View →
Q2 terminationNo activity
View →
Q1 report
View →
Q1 reportNo activity
View →
Q1 report
View →
Q4 report
View →
Registration amendment
View →
Registration
View →
Q4 report
View →
Registration
View →
Forbes-Tate
Invivyd, Inc.
Forbes-Tate
Invivyd, Inc.
King & Spalding LLP
Invivyd, Inc.
King & Spalding LLP
Forbes-Tate
Invivyd, Inc.
Invivyd, Inc.
King & Spalding LLP
Forbes-Tate
Forbes-Tate